739 results on '"Hernandez, Jonathan M."'
Search Results
102. Survival Trends and Profiling of Gastric Mixed Adenoneuroendocrine Carcinoma (gMANEC) in the Current Era
103. Author Correction: Commensal-driven immune zonation of the liver promotes host defence
104. ASO Author Reflections: Fibrolamellar Hepatocellular Carcinoma and Alpha-Fetoprotein
105. Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy.
106. Preclinical Models of Adrenocortical Cancer
107. Inhibition of Ly-49/LILRB-MHC-I interactions by anti-MHC-I augments innate and adaptive immunity.
108. An RNA Damage Response Network Mediates the Lethality of 5-FU in Clinically Relevant Tumor Types
109. Supplementary Data from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
110. Supplementary Figure from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
111. Data from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
112. Table S3 from Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma
113. Tables S1 and S2 from Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma
114. Supplemental Figures 1-15 from Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma
115. Data from Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma
116. Supplementary Figure from Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
117. Anal Carcinoma Surveillance Counterpoint: USA
118. Correction to: Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer
119. sj-pptx-2-gut-10.1177_26345161231188677 – Supplemental material for Survival Trends and Profiling of Gastric Mixed Adenoneuroendocrine Carcinoma (gMANEC) in the Current Era
120. sj-docx-1-gut-10.1177_26345161231188677 – Supplemental material for Survival Trends and Profiling of Gastric Mixed Adenoneuroendocrine Carcinoma (gMANEC) in the Current Era
121. Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
122. Patient-Derived Organoids and Their Potential for Precision Medicine in Neuroendocrine Tumors
123. Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
124. ASO Author Reflections: Using Big Data to Overcome the Challenges of Studying a Rare Tumor
125. ASO Author Reflections: Complex General Surgical Oncology Fellowships: What Are Programs Looking For?
126. CHAPTER 116 - Hemobilia and bilhemia
127. Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy
128. ASO Visual Abstract: Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials
129. A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
130. Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
131. Oregovomab Plus Chemo in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5/GOG-3035)
132. A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity (SU2C-SARC032)
133. Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials
134. Neoadjuvant Chemotherapy Plus Living Donor Transplantation (LDLT) for Non-Resectable Liver Metastases from Colorectal Cancer (CRC)
135. Neutrophil heterogeneity and emergence of a distinct population of CD11b/CD18-activated low-density neutrophils after trauma
136. Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1–3 Adrenocortical Cancer After Surgery
137. Breast Surgical Oncology Fellowship applicant selection and ranking: A survey of Society of Surgical Oncology programs
138. Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer
139. Defining the Learning Curve for Robotic-assisted Esophagogastrectomy
140. Quantitative Measures of Visceral Adiposity and Body Mass Index in Predicting Rectal Cancer Outcomes after Neoadjuvant Chemoradiation
141. Outcomes after transjugular intrahepatic portosystemic stent shunt: a “bridge” to nowhere
142. A palpable pancreatic duct
143. Patients' perceptions of laparoendoscopic single-site surgery: the cosmetic effect
144. Survival after pancreatectomy for pancreatic adenocarcinoma is not impacted by performance status
145. Complementary Strand MicroRNAs Mediate Acquisition of Metastatic Potential in Colonic Adenocarcinoma
146. Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling
147. Public Perception of LESS Surgery and NOTES
148. Decision-making and regret in patients with germlineCDH1variants undergoing prophylactic total gastrectomy
149. Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
150. Adjuvant chemotherapy is associated with improved overall survival in select patients with Stage II colon cancer: A National Cancer Database analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.